$11.7 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 102 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 60.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Sell | SPDR S&P 500 ETF TRput | $721,500,000 | -48.9% | 2,616,500 | -40.3% | 6.19% | -35.0% |
| IAC | Sell | IAC INTERACTIVECORP | $307,379,000 | -40.3% | 1,715,000 | -17.0% | 2.64% | -24.1% |
| MSFT | Sell | MICROSOFT CORP | $287,619,000 | -16.6% | 1,823,720 | -16.6% | 2.47% | +6.1% |
| CRM | Sell | SALESFORCE COM INC | $232,454,000 | -17.1% | 1,614,488 | -6.4% | 2.00% | +5.4% |
| CI | Sell | CIGNA CORP NEW | $221,475,000 | -27.8% | 1,250,000 | -16.7% | 1.90% | -8.2% |
| BABA | Sell | ALIBABA GROUP HLDG LTDsponsored ads | $218,498,000 | -9.0% | 1,123,500 | -0.8% | 1.88% | +15.7% |
| EQIX | Sell | EQUINIX INC | $176,087,000 | -27.5% | 281,933 | -32.3% | 1.51% | -7.9% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $172,126,000 | -0.5% | 5,750,000 | -8.0% | 1.48% | +26.5% |
| PANW | Sell | PALO ALTO NETWORKS INC | $161,783,000 | -36.9% | 986,721 | -11.0% | 1.39% | -19.7% |
| BRMK | Sell | BROADMARK RLTY CAP INC | $53,920,000 | -41.1% | 7,170,213 | -0.1% | 0.46% | -25.0% |
| EFX | Sell | EQUIFAX INC | $45,185,000 | -50.6% | 378,275 | -42.0% | 0.39% | -37.1% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $40,827,000 | -9.7% | 567,047 | -5.5% | 0.35% | +14.8% |
| ZEAL | Sell | ZEALAND PHARMA A Ssponsored adr | $25,875,000 | -22.8% | 750,000 | -25.7% | 0.22% | -1.8% |
| MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $22,921,000 | -57.8% | 842,683 | -69.4% | 0.20% | -46.2% |
| PRNB | Sell | PRINCIPIA BIOPHARMA INC | $22,842,000 | +4.2% | 384,674 | -3.8% | 0.20% | +32.4% |
| MYOK | Sell | MYOKARDIA INC | $20,158,000 | -86.5% | 430,000 | -79.0% | 0.17% | -82.8% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $14,500,000 | -83.6% | 3,625,000 | -12.1% | 0.12% | -79.2% |
| RC | Sell | READY CAP CORP | $9,154,000 | -63.3% | 1,267,896 | -21.6% | 0.08% | -53.0% |
| Sell | DERMTECH INC | $6,809,000 | -10.8% | 605,255 | -1.6% | 0.06% | +11.5% | |
| OPTN | Sell | OPTINOSE INC | $3,504,000 | -57.8% | 780,484 | -13.3% | 0.03% | -46.4% |
| GOSS | Sell | GOSSAMER BIO INC | $1,015,000 | -87.0% | 100,000 | -80.0% | 0.01% | -83.0% |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $341,000 | -97.9% | 50,113 | -95.4% | 0.00% | -97.3% |
| PHAS | Sell | PHASEBIO PHARMACEUTICALS INC | $280,000 | -95.4% | 84,502 | -91.5% | 0.00% | -95.1% |
| CYCN | Exit | CYCLERION THERAPEUTICS INC | $0 | – | -350,000 | -100.0% | -0.01% | – |
| APTX | Exit | APTINYX INC | $0 | – | -408,549 | -100.0% | -0.01% | – |
| ZFGN | Exit | ZAFGEN INC | $0 | – | -1,808,360 | -100.0% | -0.01% | – |
| OPK | Exit | OPKO HEALTH INC | $0 | – | -2,500,000 | -100.0% | -0.02% | – |
| OYST | Exit | OYSTER POINT PHARMA INC | $0 | – | -230,800 | -100.0% | -0.04% | – |
| ABEO | Exit | ABEONA THERAPEUTICS INC | $0 | – | -2,000,000 | -100.0% | -0.04% | – |
| GCVRZ | Exit | SANOFIright 12/31/2020 | $0 | – | -9,195,584 | -100.0% | -0.05% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -354,082 | -100.0% | -0.05% | – |
| LOGM | Exit | LOGMEIN INC | $0 | – | -130,241 | -100.0% | -0.08% | – |
| XGN | Exit | EXAGEN INC | $0 | – | -577,699 | -100.0% | -0.10% | – |
| LVGO | Exit | LIVONGO HEALTH INC | $0 | – | -600,000 | -100.0% | -0.10% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -75,000 | -100.0% | -0.10% | – |
| S | Exit | SPRINT CORPORATION | $0 | – | -3,200,000 | -100.0% | -0.11% | – |
| NLOK | Exit | NORTONLIFELOCK INC | $0 | – | -720,000 | -100.0% | -0.12% | – |
| CY | Exit | CYPRESS SEMICONDUCTOR CORP | $0 | – | -840,000 | -100.0% | -0.13% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -875,000 | -100.0% | -0.14% | – |
| AMRN | Exit | AMARIN CORP PLCcall | $0 | – | -1,000,000 | -100.0% | -0.14% | – |
| INST | Exit | INSTRUCTURE INC | $0 | – | -620,000 | -100.0% | -0.20% | – |
| TIF | Exit | TIFFANY & CO NEW | $0 | – | -225,000 | -100.0% | -0.20% | – |
| MLNX | Exit | MELLANOX TECHNOLOGIES LTD | $0 | – | -270,000 | -100.0% | -0.21% | – |
| Exit | CYPRESS SEMICONDUCTOR CORPnote 4.500% 1/1 | $0 | – | -18,645,000 | -100.0% | -0.22% | – | |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -726,986 | -100.0% | -0.24% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -442,222 | -100.0% | -0.31% | – |
| ARQL | Exit | ARQULE INC | $0 | – | -2,520,000 | -100.0% | -0.34% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INCcall | $0 | – | -400,000 | -100.0% | -0.35% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -750,000 | -100.0% | -0.38% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -1,500,000 | -100.0% | -0.40% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -750,000 | -100.0% | -0.40% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -1,190,000 | -100.0% | -0.48% | – |
| AXE | Exit | ANIXTER INTL INC | $0 | – | -917,893 | -100.0% | -0.57% | – |
| SPGI | Exit | S&P GLOBAL INC | $0 | – | -640,382 | -100.0% | -1.18% | – |
| ZAYO | Exit | ZAYO GROUP HLDGS INC | $0 | – | -6,820,000 | -100.0% | -1.60% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -3,315,000 | -100.0% | -1.90% | – |
| SMH | Exit | VANECK VECTORS ETF TRUSTput | $0 | – | -2,505,000 | -100.0% | -2.39% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -2,400,000 | -100.0% | -5.35% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
| RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
| GRIFOLS S A | 33 | Q4 2021 | 0.9% |
| ALPHABET INC | 32 | Q3 2023 | 4.2% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
| VISA INC | 30 | Q3 2023 | 2.9% |
| WABTEC CORP | 27 | Q3 2023 | 3.6% |
| EXELIXIS INC | 27 | Q3 2023 | 2.8% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
| SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
| Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
| Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
| AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
| Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
| Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
| ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
| Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
| Solid Power, Inc. | February 11, 2022 | ? | ? |
| Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR/A | 2024-02-12 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-01-23 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.